Vectorious Medical Technologies

Vectorious Medical Technologies is a medical technology company focused on developing implantable sensor-based therapies for managing heart health, particularly chronic heart failure. Their mission is to create scalable therapies that provide reliable and actionable clinical information, aiming to establish themselves as a center of excellence in this field. The company's flagship product, the V-LAP platform, features an implantable sensor that measures left atrial pressure (LAP) continuously. This sensor is placed in the heart's interatrial septum and transmits daily data, enabling both physician-guided and patient self-management of chronic heart failure. The V-LAP system allows for real-time monitoring of heart function, facilitating early detection and improved management of heart failure symptoms, which can enhance patient outcomes and reduce hospitalizations. Vectorious has built the largest dataset of left atrial pressure measurements globally, highlighting the extensive clinical application of their technology. The company fosters a collaborative culture focused on passion, critical thinking, and adaptability, committed to making a meaningful impact on patients' lives through their innovative medical solutions.

• Employees 110
• Founded 2011
• Total Funding $19000000